Companies the National Stock Exchange of India classifies as Pharmaceuticals announced 2 orders to the exchange between 23 February 2026 and 5 August 2026, worth ₹825 Cr across the 1 that named an amount. 2 companies filed them.
Pharmaceuticals orders announced
₹825 Cr
1 of 2 filings named an amount
What that figure leaves out, said plainly rather than left to be worked out: 1 filing named no rupee amount, or named one in another currency — counted as announcements, absent from the total, because River does not hold the exchange rate the company used. Filings that restate a standing order book rather than announce new work are excluded, and so are repeat filings of an order already announced — a press release and a formal intimation for the same work count once. River does not project any of this into revenue and does not say whether it is good news.
Newest first. The link on each goes to the company's own document, not to another River page.
We are now delighted to inform you that in terms of the aforesaid Long-Term Agreement, the Company has received Letter of Award for supply of bOPV in 10 and 20 dose presentation worth ~US$ 8.205 million (~Rs.78.24 Crore) in Calendar Year 20
from UNICEF · source filing
Morepen Bags ₹825 Crore Global Deal; Expands Into High-Growth CDMO Segment
from USFDA · source filing
UnclassifiedElectrical EquipmentTransmission TowersConstructionSteel And Steel ProductsPowerElectronics - IndustrialEngineeringTelecommunication - EquipmentMining
Industry is the classification the National Stock Exchange of India records for the announcing company, not River's judgement about what the company does. River reproduces what was filed and links to it. River is not an investment adviser and does not give investment advice.